Question-based Drug Development for psilocybin

Abstract

Robin Carhart-Harris and colleagues1 conclude that there is preliminary support for the safety and efficacy of psilocybin for treatment-resistant unipolar depression. This finding is important because more effective pharmacological treatments with acceptable side-effects …